Patent · US Expired

Calcification-resistant materials and methods of making same through use of multivalent cations

US5368608A · kind A · utility

141Cited by
12References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 23, 1991
Grant dateNov 29, 1994
Priority date
Expiry dateApr 23, 2011

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S623/921
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Bioprosthetic materials, either natural or synthetic, are treated with trivalent aluminum or iron cations, or salts, to prevent in vivo calcification. Such bioprosthetic materials include porcine aortic valve leaflets, bovine pericardium, aortic homografts, biocompatible elastomers, and the like which are intended for invasive, or in-dwelling use in a human or animal body. Simple incubation of the natural bioprosthetic materials in an ion-containing solution, such as aqueous AlCl.sub.3 or FeCl.sub.3, prior to implantation has been found to inhibit calcification of the biomaterial over a prolonged period, and to do so without adverse side effects. Incorporation of an aluminum-containing compound into the formulation for polymers, such as polyurethane, has also been found to inhibit calcification with no adverse side effects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.